Skip to main content
. 2011 Sep 26;17(Suppl 6):E1–E59. doi: 10.1111/j.1469-0691.2011.03672.x
Reference Objective Design Evidence
Black et al. [484] Prophylatic antibiotics for chronic bronchitis MA 1A+
Smucny et al. [485] Antibiotics for acute bronchitis MA 1A−
Sethi et al. [487] Proof‐of‐concept study evaluates whether intermittent pulsed moxifloxacin treatment (5 days/8 weeks) could reduce the frequency of these exacerbations RCT 2A−